Skip to main content
Log in

Evaluation of the brain uptake properties of [1-11C]labeled hexanoate in anesthetized cats by means of positron emission tomography

  • Short Communication
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Positron emission tomography (PET) was performed on the cat brain to characterize [1-11C]hexanoate and other [1-11C]labeled short and medium-chain fatty acids as a tracer of fatty acid oxidative metabolism. After an intravenous injection the brain uptake of [1-11C]hexanoate reached a peak followed by rapid washout until 2 min (first phase). Subsequently the total brain uptake was again increased and reached to a peak 7–10 min after tracer injection (second phase). The blood radioactivity of unmetabolized [1-11C]hexanoate was rapidly decreased and almost eliminated within the first 2 min, whereas the blood radioactivity of [11C]CO2/HCO3 was gradually increased and reached a peak approximately 5 min after tracer injection. As the effect of circulating [11C]CO2/ HCO3 was examined by a bolus intravenous injection of [11C]CO2/HCO3 , the brain uptake of [11C]CO2/HCO3 was rapidly increased right after the injection and changed parallel to the blood level of [11C]CO2/HCO3 .

These results suggest that, in contrast to the previous mouse data, the time-activity curve in the cat brain following intravenous injection of [l-11C]hexanoate has a biphasic pattern, the second phase being determined by peripherally originating [11C]CO2/HCO3 , and therefore does not reflect the metabolism of11C-labeled fatty acid in the brain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Storch-Becker A, Kaiser KP, Feinendegen LE. Cardiac nuclear medicine: positron emission tomography in clinical medicine.Eur J Nucl Med 13: 648–652, 1988.

    Article  PubMed  CAS  Google Scholar 

  2. Jacobson HG. Application of positron emission tomography in the heart.J Am Med Assoc 259: 2438–2445, 1988.

    Article  Google Scholar 

  3. Sokoloff L. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system.Fed Proc 40: 2311–2316, 1981.

    PubMed  CAS  Google Scholar 

  4. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF. Brain metabolism during fasting.J Clin Invest 46: 1589–1595, 1967.

    Article  PubMed  CAS  Google Scholar 

  5. Beattie DS, Basford RE. Brain mitochondria—III. Fatty acid oxidation by bovine brain mitochondria.J Neurochem 12: 103–111, 1965.

    Article  PubMed  CAS  Google Scholar 

  6. Hawkins RA, Mans AM, Davis DW, Vina JR, Hibbard LS. Cerebral glucose use measured with [14C]glucose labeled in the 1, 2, or 6 position.Am J Physiol 248: C170-C176, 1985.

    PubMed  CAS  Google Scholar 

  7. Cremer JE, Teal HM, Heath DF, Cavanagh JB. The influence of portocaval anastomosis on the metabolism of labeled octanoate, butyrate and leucine in rat brain.J Neurochem 28: 215–222, 1974.

    Article  Google Scholar 

  8. Rowley H, Collins RC. [1-14C]octanoate: a fast functional marker of brain activity.Brain Res 335: 326–329, 1985.

    Article  PubMed  CAS  Google Scholar 

  9. Ishiwata K, Ishii K, Ogawa K, Nozaki T, Senda M. A brain uptake study of [l-11C]hexanoate in the mouse: the effect of hypoxia, starvation and substrate competition.Ann Nucl Med 10: 265–270, 1996.

    Article  PubMed  CAS  Google Scholar 

  10. Oldendorf WH. Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids.Am J Physiol 224: 1450–1453, 1973.

    PubMed  CAS  Google Scholar 

  11. Ishiwata K, Ishii K, Ogawa K, Sasaki T, Toyama H, Ishii S, et al. Synthesis and preliminary evaluation of [1-11C]hexanoate as a PET tracer of fatty acid metabolism.Ann Nucl Med 9: 51–57, 1995.

    PubMed  CAS  Google Scholar 

  12. Ishiwata K, Ishii S, Senda M. Successive preparation of C-11 labeled sodium acetate and/or sodium [1-11C]hexanoate.Appl Radiat Isot 46: 1035–1037, 1995.

    Article  CAS  Google Scholar 

  13. Watanabe M, Uchida H, Okada K, Shimizu K, Satoh E, Yoshikawa T, et al. A high resolution PET for animal studies.IEEE Trans Med Imag 11: 577–580, 1992.

    Article  CAS  Google Scholar 

  14. Shields AF, Graham MM, Kozawa SM, Kozell LB, Link JM, Swenson ER, et al. Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds.J Nucl Med 33: 581–586, 1992.

    PubMed  CAS  Google Scholar 

  15. Kuge Y, Yajima K, Kawashima H, Yamazaki H, Hashimoto N, Miyake Y. Brain uptake and metabolism of [l-11C]octanoate in rats: Pharmacokinetic basis for its application as a radiopharmaceutical for studying brain fatty acid metabolism.Ann Nucl Med 9: 137–142, 1995.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakiyama, Y., Ishiwata, K., Ishii, K. et al. Evaluation of the brain uptake properties of [1-11C]labeled hexanoate in anesthetized cats by means of positron emission tomography. Ann Nucl Med 10, 361–366 (1996). https://doi.org/10.1007/BF03164748

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03164748

Key words

Navigation